Syndicated News

This blog is still in BETA

We are aware of any formatting errors. These stories are automatically pulled from RSS feeds. Due to the automated nature of the post, some images may appear small, and some links may not be clickable until our staff has had the opportunity to manicure the postings. Thank you for understanding.

December 01, 2014

Baxter seeks OK to sell new hemophilia drug - Chicago Tribune

December 01, 2014/ Michael

http://bit.ly/1wcM7kb Click to read full article...

Baxter seeks OK to sell new hemophilia drugChicago Tribune"The evidence from our late-stage controlled trial showcases that BAX 855 could become an important new treatment option for people with hemophilia A, expanding on more than a decade of experience with Advate," said Dr. John Orloff, vice president and ...Baxter submits BLA for extended half-life hemophilia treatment (BAX)Seeking AlphaBaxter Submits BLA For BAX 855Nasdaqall 7 news articles »

from Hemophilia - Google News http://bit.ly/1wcM7kb via IFTTT

Committee of Ten Thousand

ADVOCATES FOR PERSONS WITH HIV/AIDS, HEMOPHILIA, HCV, AND SICKLE CELL

MONITORING THE BLOOD SUPPLY AND PROTECTING PATIENT RIGHTS SINCE 1989

The Committee of Ten Thousand is a grass-roots, peer-led, education, advocacy and support organization. The majority of our constituency is persons with hemophilia who contracted HIV/AIDS from tainted blood products. We work in solidarity with all communities affected by the HIV/AIDS pandemic. COTT advocates for disenfranchised chronic disease communities, especially those communities dependent on a safe national blood supply. We are dedicated to the belief that persons with HIV/AIDS and all chronic diseases can lead productive and healthy lives.

Syndicated News

Syndicated News Feed

Baxter seeks OK to sell new hemophilia drug - Chicago Tribune

Committee of Ten Thousand

Quick Links - Sections